CLS Holdings plc (LON:CLI - Get Free Report)'s share price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 73.40 ($0.98) and traded as low as GBX 60.10 ($0.80). CLS shares last traded at GBX 61 ($0.81), with a volume of 187,285 shares traded.
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank reissued a "buy" rating and set a GBX 114 ($1.52) price objective on shares of CLS in a research note on Tuesday, April 1st.
View Our Latest Stock Analysis on CLS
CLS Trading Up 1.1%
The company has a quick ratio of 0.59, a current ratio of 0.73 and a debt-to-equity ratio of 123.30. The firm has a market capitalization of £245.87 million, a P/E ratio of -1.19 and a beta of 1.01. The firm's 50-day simple moving average is GBX 64 and its 200-day simple moving average is GBX 73.40.
CLS (LON:CLI - Get Free Report) last posted its quarterly earnings data on Tuesday, April 1st. The company reported GBX (23.60) (($0.32)) earnings per share for the quarter. CLS had a negative net margin of 134.11% and a negative return on equity of 23.42%. Analysts anticipate that CLS Holdings plc will post 10.0104167 EPS for the current year.
CLS Increases Dividend
The company also recently declared a dividend, which will be paid on Tuesday, June 3rd. Shareholders of record on Thursday, May 15th will be paid a dividend of GBX 2.68 ($0.04) per share. The ex-dividend date of this dividend is Thursday, May 15th. This represents a yield of 4.17%. This is a positive change from CLS's previous dividend of $2.60. CLS's payout ratio is -15.42%.
CLS Company Profile
(
Get Free Report)
We are a commercial property investment company with a £2.1bn portfolio listed on the Premium Main Market on the London Stock Exchange, specialising in future-focused office space in the UK, Germany and France. Through geographical diversification, local expertise and an active management approach, we transform office properties into sustainable, modern spaces that help our tenants' businesses to grow.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CLS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CLS wasn't on the list.
While CLS currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.